ESMAX
Price
$15.46
Change
-$0.09 (-0.58%)
Updated
Nov 13 closing price
VEURX
Price
$34.84
Change
-$0.20 (-0.57%)
Updated
Nov 13 closing price
Ad is loading...

ESMAX vs VEURX

Header iconESMAX vs VEURX Comparison
Open Charts ESMAX vs VEURXBanner chart's image
Invesco EQV Euro Small Company A
Price$15.46
Change-$0.09 (-0.58%)
VolumeN/A
CapitalizationN/A
Vanguard European Stock Investor
Price$34.84
Change-$0.20 (-0.57%)
VolumeN/A
CapitalizationN/A
ESMAX vs VEURX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ESMAX vs. VEURX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ESMAX is a StrongSell and VEURX is a Sell.

FUNDAMENTALS
Fundamentals
VEURX has more cash in the bank: 24.5B vs. ESMAX (175M). ESMAX pays higher dividends than VEURX: ESMAX (4.19) vs VEURX (3.11). ESMAX was incepted earlier than VEURX: ESMAX (24 years) vs VEURX (34 years). ESMAX is a more actively managed with annual turnover of: 24.00 vs. VEURX (4.00). VEURX has a lower initial minimum investment than ESMAX: VEURX (0) vs ESMAX (1000). ESMAX annual gain was more profitable for investors over the last year : 13.52 vs. VEURX (7.86). ESMAX return over 5 years is better than : 23.90 vs. VEURX (16.05).
ESMAXVEURXESMAX / VEURX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years34 years-
Gain YTD3.8280.574667%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets175M24.5B1%
Annual Yield % from dividends4.193.11135%
Returns for 1 year13.527.86172%
Returns for 3 years-7.58-6.38119%
Returns for 5 years23.9016.05149%
Returns for 10 years36.6124.95147%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FWONA78.443.46
+4.61%
Liberty Media Corp
PAM73.972.28
+3.18%
Pampa Energia SA
LVO0.89N/A
+0.02%
LiveOne
VINC0.32-0.01
-4.24%
Vincerx Pharma
CAPR16.91-1.19
-6.57%
Capricor Therapeutics